Among the multiple sleep dimensions, patients in the LAF & ESO group exhibited more remarkable improvements in subjective sleep quality, sleep disturbance, and used sleep medication, though these differences did not reach statistical significance (Supplementary Table 2 ).
← all excerpts
Addition of bedtime lafutidine inhibits nocturnal acid-breakthrough and improves sleep quality in gastroesophageal reflux disease patients on esomeprazole: a randomized controlled trial.
1
—
—